{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:43:54Z","timestamp":1794015834803,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"am","delay-in-days":282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.steroids.2022.108998","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T01:59:29Z","timestamp":1646618369000},"page":"108998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Differential off-target glucocorticoid activity of progestins used in endocrine therapy"],"prefix":"10.1016","volume":"182","author":[{"given":"Maleshigo","family":"Komane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanel","family":"Avenant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Louw-du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita J.","family":"Africander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet P.","family":"Hapgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.steroids.2022.108998_b0010","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2022.108998_b0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsbmb.2013.12.003","article-title":"The \u201cnewer\u201d progestogens and postmenopausal hormone therapy (HRT)","volume":"142","author":"Schindler","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.steroids.2022.108998_b0020","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-11-4064","article-title":"Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"issue":"9382","key":"10.1016\/j.steroids.2022.108998_b0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"MillionWomenStudyCollaborators","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.steroids.2022.108998_b0030","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.NAJ.0000654304.29632.a7","article-title":"CE: an evidence-based update on contraception","volume":"120","author":"Britton","year":"2020","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.steroids.2022.108998_b0040","first-page":"1","article-title":"The clinical impact of estrogen loss on cardiovascular disease in menopausal females","volume":"6","author":"Lopez-Pier","year":"2018","journal-title":"Med. Res. Arch."},{"issue":"13","key":"10.1016\/j.steroids.2022.108998_b0045","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2022.108998_b0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/13697137.2013.802556","article-title":"Progesterone and related progestins: potential new health benefits","volume":"16","author":"Sitruk-Ware","year":"2013","journal-title":"Climacteric"},{"issue":"17","key":"10.1016\/j.steroids.2022.108998_b0055","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/er.2017-00103","article-title":"Hormonal contraception and HIV-1 acquisition: biological mechanisms","volume":"39","author":"Hapgood","year":"2018","journal-title":"Endocr. Rev."},{"issue":"1-2","key":"10.1016\/j.steroids.2022.108998_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","article-title":"Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy","volume":"491","author":"Louw-du Toit","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0075","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2020.03.100","article-title":"A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor","volume":"526","author":"Louw-du Toit","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0085","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2022.108998_b0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coemr.2020.10.001","article-title":"Progestins in menopausal hormone therapy and breast cancer risk: the debate continues","volume":"15","author":"Africander","year":"2020","journal-title":"Curr. Opin. Endocrine Metabolic Res."},{"key":"10.1016\/j.steroids.2022.108998_b0095","doi-asserted-by":"crossref","unstructured":"Cancer, C.G.o.H.F.i.B., 2019. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 394(10204), 1159-1168. DOI: 10.1016\/s0140-6736(19)31709-x.","DOI":"10.1016\/S0140-6736(19)31709-X"},{"issue":"11","key":"10.1016\/j.steroids.2022.108998_b0100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","article-title":"Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction","volume":"299","author":"Ronacher","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2022.108998_b0110","doi-asserted-by":"crossref","first-page":"e0196043","DOI":"10.1371\/journal.pone.0196043","article-title":"Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4\/CD8 ratios and CCR5 levels","volume":"13","author":"Maritz","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-40756-7","article-title":"The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations","volume":"9","author":"Ray","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.steroids.2022.108998_b0120","first-page":"4055","article-title":"Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes","volume":"84","author":"Bamberger","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"45","key":"10.1016\/j.steroids.2022.108998_b0125","doi-asserted-by":"crossref","first-page":"31136","DOI":"10.1074\/jbc.M114.587311","article-title":"Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner","volume":"289","author":"Louw-du Toit","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2022.108998_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.572981","article-title":"Multifaceted control of GR signaling and its impact on hepatic transcriptional networks and metabolism","volume":"11","author":"Pr\u00e6stholm","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.steroids.2022.108998_b0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2017.02.005","article-title":"Glucocorticoids and reproduction: traffic control on the road to reproduction","volume":"28","author":"Whirledge","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.steroids.2022.108998_b0140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/physrev.00011.2015","article-title":"Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy","volume":"96","author":"Hartmann","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.steroids.2022.108998_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01859","article-title":"Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor","volume":"10","author":"Escoter-Torres","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing\u2019s syndrome: from physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives","volume":"129","author":"Cromer","year":"1996","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-019-4555-y","article-title":"Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia","volume":"12","author":"Zerihun","year":"2019","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.steroids.2022.108998_b0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0015-0282(16)38880-X","volume":"23","author":"Spellacy","year":"1972","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2022.108998_b0175","first-page":"6","article-title":"Effect of Depo-medroxyprogesterone acetate (DMPA) on Lipid Metabolism","volume":"6","author":"Fekadie","year":"2016","journal-title":"Int. J. Res. Biotechnol. Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-021-01178-8","article-title":"Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study","volume":"21","author":"Shiferaw","year":"2021","journal-title":"BMC Womens Health"},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0185","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.amjms.2016.08.007","article-title":"Cardiovascular disease risk associated with the long-term use of depot medroxyprogesterone acetate","volume":"352","author":"Dilshad","year":"2016","journal-title":"Am. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.steroids.2022.108998_b0190","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1172\/JCI120583","article-title":"Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity","volume":"128","author":"Zalenskaya","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2022.108998_b0195","unstructured":"Matubu, T.A., et al., Effect of Depot-medroxyprogesterone Acetate on T Cell Expression of Immunosuppressive Markers, PD-1 and CTLA-4 in HIV-negative Women. AIDS Research and Human Retroviruses, 2018. 34(S1)DOI: Abstract no. OA12.04."},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13405","article-title":"Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation","volume":"86","author":"Matubu","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.steroids.2022.108998_b0205","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.eclinm.2021.100800","article-title":"Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: findings from a randomised, multicentre, open-label trial","volume":"34","author":"Beksinska","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.steroids.2022.108998_b0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/ph14060548","article-title":"Safety and benefits of contraceptives implants: a systematic review","volume":"14","author":"Rocca","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0215","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0002-9378(93)90335-G","article-title":"Effects of desogestrel on carbohydrate metabolism","volume":"168","author":"Shoupe","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0220","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0002-9378(89)80014-6","article-title":"Norplant: subdermal implant system for long-term contraception","volume":"160","author":"Shoupe","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10\u201311","key":"10.1016\/j.steroids.2022.108998_b0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0039-128X(00)00124-0","article-title":"Progestin implants","volume":"65","author":"Croxatto","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2022.108998_b0230","doi-asserted-by":"crossref","first-page":"107789","DOI":"10.1016\/j.pharmthera.2020.107789","article-title":"Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception","volume":"222","author":"Bick","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.steroids.2022.108998_b0235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of Levonogestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saftey"},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","article-title":"Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years","volume":"109","author":"Pongsatha","year":"2010","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0010-7824(01)00182-2","article-title":"Implanon\u00ae contraceptive implants: effects on carbohydrate metabolism","volume":"63","author":"Biswas","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2022.108998_b0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2016.04.025","article-title":"Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period","volume":"202","author":"Villas-Boas","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.steroids.2022.108998_b0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(91)90032-B","article-title":"Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile","volume":"44","author":"Fahmy","year":"1991","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(83)90247-4","article-title":"A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women","volume":"132","author":"Parish","year":"1983","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0270","first-page":"855","article-title":"Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435","volume":"80","author":"Laurikka-Routti","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.contraception.2003.10.003","article-title":"Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women","volume":"69","author":"Sivin","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.steroids.2022.108998_b0280","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2020.09.058","article-title":"Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor","volume":"533","author":"Enfield","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.steroids.2022.108998_b0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.steroids.2022.108998_b0290","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.steroids.2022.108998_b0295","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/mi.2016.22","article-title":"Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection","volume":"9","author":"Quispe Calla","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0300","doi-asserted-by":"crossref","first-page":"e96497","DOI":"10.1371\/journal.pone.0096497","article-title":"The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor","volume":"9","author":"Govender","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2022.108998_b0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(94)00003-F","article-title":"Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays","volume":"51","author":"Fuhrmann","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2022.108998_b0310","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0010-7824(92)90121-9","article-title":"Dihydrospiroremine (ZK30595): a novel synthetic prixestagen characterization of binding to different receptor protein","volume":"46","author":"Pollow","year":"1992","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2022.108998_b0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2022.108998_b0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsbmb.2019.02.010","article-title":"Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms","volume":"189","author":"Skosana","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"15","key":"10.1016\/j.steroids.2022.108998_b0325","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1073\/pnas.94.15.7879","article-title":"Steroid receptor induction of gene transcription: a two-step model","volume":"94","author":"Jenster","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.steroids.2022.108998_b0330","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/me.2007-0219","article-title":"Glucocorticoid receptor phosphorylation differentially affects target gene expression","volume":"22","author":"Chen","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"29","key":"10.1016\/j.steroids.2022.108998_b0335","doi-asserted-by":"crossref","first-page":"26573","DOI":"10.1074\/jbc.M110530200","article-title":"Deciphering the phosphorylation \u201ccode\u201d of the glucocorticoid receptor in vivo","volume":"277","author":"Wang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2022.108998_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112379","article-title":"GR-mediated anti-inflammation of alpha-boswellic acid: Insights from in vitro and in silico studies","volume":"155","author":"Zhang","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"23","key":"10.1016\/j.steroids.2022.108998_b0345","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1039\/D1FO01612A","article-title":"Glucocorticoid receptor-mediated alleviation of inflammation by berberine: in vitro, in silico and in vivo investigations","volume":"12","author":"Liang","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.steroids.2022.108998_b0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2017.07.022","article-title":"A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-alpha and -beta","volume":"174","author":"Perkins","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2022.108998_b0355","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quatitites of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0360","doi-asserted-by":"crossref","first-page":"e62895","DOI":"10.1371\/journal.pone.0062895","article-title":"The progestin-only contraceptive medroxyprogesteroneacetate, but not norethisterone acetate, enhances HIV-1Vpr-mediated apoptosis in human CD4+T cells throughthe glucocorticoid receptor","volume":"8","author":"Tomasicchio","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1183\/09031936.02.00303602","article-title":"Tumour necrosis factor-alpha induced CD70 and interleukin-7R mRNA expression in BEAS-2B cells","volume":"20","author":"Wolf","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0370","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1210\/jc.2002-021353","article-title":"Sex steroid hormone receptors in human thymoma","volume":"88","author":"Ishibashi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"900","key":"10.1016\/j.steroids.2022.108998_b0375","first-page":"2002","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"1-2","key":"10.1016\/j.steroids.2022.108998_b0380","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mce.2010.06.007","article-title":"Role of ligand-dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity","volume":"327","author":"Avenant","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108998_b0385","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/bi901956s","article-title":"Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment","volume":"49","author":"Avenant","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.steroids.2022.108998_b0390","doi-asserted-by":"crossref","first-page":"104802","DOI":"10.1016\/j.phrs.2020.104802","article-title":"Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor","volume":"156","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.steroids.2022.108998_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652800","article-title":"GILZ regulates the expression of pro-inflammatory cytokines and protects against end-organ damage in a model of lupus","volume":"12","author":"Nataraja","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.steroids.2022.108998_b0400","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2015.11.023","article-title":"Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice","volume":"64","author":"Robert","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.steroids.2022.108998_b0405","doi-asserted-by":"crossref","first-page":"112413","DOI":"10.1016\/j.fct.2021.112413","article-title":"In vitro and in silico investigations of endocrine disruption induced by metabolites of plasticizers through glucocorticoid receptor","volume":"155","author":"Leng","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.steroids.2022.108998_b0410","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a uniquie pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.steroids.2022.108998_b0415","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.contraception.2010.11.017","article-title":"Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey","volume":"84","author":"van Diepen","year":"2011","journal-title":"Contraception"},{"issue":"13-14","key":"10.1016\/j.steroids.2022.108998_b0420","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.intimp.2003.08.005","article-title":"Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression","volume":"3","author":"Zhao","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.steroids.2022.108998_b0425","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41574-020-0349-5","article-title":"Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation","volume":"16","author":"De Bosscher","year":"2020","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:08:17Z","timestamp":1758535697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X22000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":85,"alternative-id":["S0039128X22000368"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2022.108998","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential off-target glucocorticoid activity of progestins used in endocrine therapy","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2022.108998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108998"}}